Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Yan Pei

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|March 29, 2013
The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repairYun Dai, Shuang Chen, Maciej Kmieciak, et al.
Blood|June 2, 2007
MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanismXin-Yan Pei, Yun Dai, Sarah Tenorio, et al.
British Journal of Haematology|March 8, 2011
Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and BimYun Dai, Shuang Chen, Li Wang, et al.
Blood|May 29, 2008
Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylateYun Dai, Shuang Chen, Charis A Venditti, et al.
Blood|October 21, 2004
Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNKYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Hepatology (Baltimore, Md.)|March 27, 2002
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytesLiang Qiao, Adly Yacoub, Elaine Studer, et al.
The Journal of Biological Chemistry|August 6, 2011
Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitorsYun Dai, Shuang Chen, Li Wang, et al.
Blood|July 11, 2008
Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cellsYun Dai, Shuang Chen, Xin-Yan Pei, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Nonlinear response surface in the study of interaction analysis of three combination drugsWen Wan, Xin-Yan Pei, Steven Grant, et al.
Blood|December 15, 2010
Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivoYun Dai, Shuang Chen, Rena Shah, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|March 29, 2013
The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repairYun Dai, Shuang Chen, Maciej Kmieciak, et al.
Blood|June 2, 2007
MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanismXin-Yan Pei, Yun Dai, Sarah Tenorio, et al.
British Journal of Haematology|March 8, 2011
Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and BimYun Dai, Shuang Chen, Li Wang, et al.
Blood|May 29, 2008
Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylateYun Dai, Shuang Chen, Charis A Venditti, et al.
Blood|October 21, 2004
Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNKYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Hepatology (Baltimore, Md.)|March 27, 2002
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytesLiang Qiao, Adly Yacoub, Elaine Studer, et al.
The Journal of Biological Chemistry|August 6, 2011
Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitorsYun Dai, Shuang Chen, Li Wang, et al.
Blood|July 11, 2008
Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cellsYun Dai, Shuang Chen, Xin-Yan Pei, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Nonlinear response surface in the study of interaction analysis of three combination drugsWen Wan, Xin-Yan Pei, Steven Grant, et al.
Blood|December 15, 2010
Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivoYun Dai, Shuang Chen, Rena Shah, et al.
Pageof 3